Väljaminev kiriAvalik
Farmakopöa töökava asjus
Ravimiamet · 27. jaanuar 2025
- Viit
- REP-1/396-2
- Registreeritud
- 27. jaanuar 2025
- Dokumendi liik
- Väljaminev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2025
- Vastutaja
- Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)
Sisu (failidest)
Addition to the work programme P4: Pitolisant hydrochloride and Pitolisant
hydrochloride tablets
page 1 / 3
Q1-4 (3907)
NPA: (51008)
Type: (!/list-dropdown)
A10 - Estonia (EE)
Please inform if you are in favour of the addition of Pitolisant hydrochloride to the work
programme.
(51009)
Type: (L/list-radio)
In favour of the addition of Pitolisant hydrochloride to the work programme
A1
page 2 / 3
Please inform if you are in favour of the addition of Pitolisant hydrochloride tablets to the work
programme:
(51012)
Type: (L/list-radio)
In favour of the addition of Pitolisant hydrochloride tablets to the work programme
A1
If opposed to these additions to the work programme, please state why (51010)
Type: (T/text-long)
-
Remarks: (51011)
Type: (T/text-long)
-
page 3 / 3